Amalgamated Bank Exact Sciences Corp Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Exact Sciences Corp stock. As of the latest transaction made, Amalgamated Bank holds 10,634 shares of EXAS stock, worth $586,252. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,634
Previous 10,937 2.77%
Holding current value
$586,252
Previous $462,000 56.71%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$42.43 - $70.83 $12,856 - $21,461
-303 Reduced 2.77%
10,634 $724,000
Q2 2024

Aug 12, 2024
BUY
$41.33 - $74.26 $11,737 - $21,089
284 Added 2.67%
10,937 $462,000
Q1 2024

Apr 23, 2024
SELL
$56.27 - $73.77 $1.04 Million - $1.37 Million
-18,535 Reduced 63.5%
10,653 $736,000
Q4 2023

Feb 06, 2024
SELL
$59.06 - $75.72 $218,699 - $280,391
-3,703 Reduced 11.26%
29,188 $2.16 Million
Q3 2023

Nov 08, 2023
BUY
$65.94 - $99.04 $132,605 - $199,169
2,011 Added 6.51%
32,891 $2.24 Million
Q2 2023

Aug 11, 2023
BUY
$62.68 - $95.05 $91,074 - $138,107
1,453 Added 4.94%
30,880 $2.9 Million
Q1 2023

May 02, 2023
SELL
$47.19 - $70.77 $206,503 - $309,689
-4,376 Reduced 12.95%
29,427 $2 Million
Q4 2022

Feb 10, 2023
BUY
$30.35 - $53.15 $14,719 - $25,777
485 Added 1.46%
33,803 $1.67 Million
Q3 2022

Nov 09, 2022
BUY
$31.97 - $49.37 $13,874 - $21,426
434 Added 1.32%
33,318 $1.08 Million
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $490,492 - $1.05 Million
13,774 Added 72.08%
32,884 $1.3 Million
Q1 2022

Jun 30, 2022
BUY
$57.56 - $82.54 $214,238 - $307,213
3,722 Added 24.19%
19,110 $1.34 Million
Q4 2021

Feb 15, 2022
BUY
$72.5 - $100.68 $353,147 - $490,412
4,871 Added 46.32%
15,388 $1.2 Million
Q3 2021

Oct 29, 2021
SELL
$90.24 - $124.05 $149,347 - $205,302
-1,655 Reduced 13.6%
10,517 $1 Million
Q2 2021

Aug 16, 2021
BUY
$93.66 - $139.27 $467,644 - $695,375
4,993 Added 69.55%
12,172 $1.51 Million
Q1 2021

May 13, 2021
SELL
$116.57 - $155.01 $48,726 - $64,794
-418 Reduced 5.5%
7,179 $946,000
Q4 2020

Feb 12, 2021
SELL
$99.61 - $142.12 $11,156 - $15,917
-112 Reduced 1.45%
7,597 $1.01 Million
Q3 2020

Oct 30, 2020
SELL
$72.92 - $102.01 $8,531 - $11,935
-117 Reduced 1.5%
7,709 $786,000
Q2 2020

Aug 10, 2020
SELL
$55.75 - $92.75 $1.58 Million - $2.64 Million
-28,421 Reduced 78.41%
7,826 $680,000
Q1 2020

May 13, 2020
SELL
$37.9 - $104.44 $30,092 - $82,925
-794 Reduced 2.14%
36,247 $2.1 Million
Q4 2019

Feb 13, 2020
BUY
$77.66 - $99.74 $356,692 - $458,105
4,593 Added 14.15%
37,041 $3.43 Million
Q3 2019

Nov 13, 2019
BUY
$90.37 - $122.49 $378,379 - $512,865
4,187 Added 14.82%
32,448 $2.93 Million
Q2 2019

Aug 14, 2019
BUY
$89.51 - $118.04 $87,182 - $114,970
974 Added 3.57%
28,261 $3.34 Million
Q1 2019

May 15, 2019
BUY
$61.98 - $96.5 $30,990 - $48,250
500 Added 1.87%
27,287 $2.36 Million
Q4 2018

Feb 15, 2019
BUY
$56.04 - $82.66 $582,759 - $859,581
10,399 Added 63.45%
26,787 $1.69 Million
Q3 2018

Nov 14, 2018
SELL
$48.29 - $80.6 $560,453 - $935,443
-11,606 Reduced 41.46%
16,388 $1.29 Million
Q2 2018

Jul 18, 2018
BUY
$37.84 - $69.96 $465,242 - $860,158
12,295 Added 78.32%
27,994 $1.67 Million
Q1 2018

May 22, 2018
SELL
$39.82 - $57.53 $11,906 - $17,201
-299 Reduced 1.87%
15,699 $633,000
Q4 2017

Feb 13, 2018
BUY
$46.49 - $60.51 $48,070 - $62,567
1,034 Added 6.91%
15,998 $841,000
Q3 2017

Nov 09, 2017
BUY
$37.05 - $47.12 $554,416 - $705,103
14,964
14,964 $705,000

Others Institutions Holding EXAS

# of Institutions
670
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.76B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email